
Randall E Chin
Examiner (ID: 12915)
Most Active Art Unit | 3723 |
Art Unit(s) | 3723, 2899, 1744, 3405, 2402 |
Total Applications | 3332 |
Issued Applications | 2401 |
Pending Applications | 211 |
Abandoned Applications | 665 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6033176
[patent_doc_number] => 20110082110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/966629
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13230
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082110.pdf
[firstpage_image] =>[orig_patent_app_number] => 12966629
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966629 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION | Dec 12, 2010 | Abandoned |
Array
(
[id] => 10857566
[patent_doc_number] => 08883765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Anti-cytomegalovirus activity of artemisinin-derived dimers'
[patent_app_type] => utility
[patent_app_number] => 13/514645
[patent_app_country] => US
[patent_app_date] => 2010-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27308
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514645
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/514645 | Anti-cytomegalovirus activity of artemisinin-derived dimers | Dec 7, 2010 | Issued |
Array
(
[id] => 5976122
[patent_doc_number] => 20110070300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'EXTENDED RELEASE DOSAGE FORMS OF METOPROLOL'
[patent_app_type] => utility
[patent_app_number] => 12/954644
[patent_app_country] => US
[patent_app_date] => 2010-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3844
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20110070300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12954644
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/954644 | Extended release dosage forms of metoprolol | Nov 24, 2010 | Issued |
Array
(
[id] => 7580945
[patent_doc_number] => 20110294828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'PROCESS FOR PREPARING A POLYMORPH OF THE CHOLINE SALT OF A PYRIMIDIN-5-YL ACETIC ACID DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 12/950099
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11703
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294828.pdf
[firstpage_image] =>[orig_patent_app_number] => 12950099
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/950099 | PROCESS FOR PREPARING A POLYMORPH OF THE CHOLINE SALT OF A PYRIMIDIN-5-YL ACETIC ACID DERIVATIVE | Nov 18, 2010 | Abandoned |
Array
(
[id] => 7561853
[patent_doc_number] => 20110275686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'NANOPARTICLE CARRIER SYSTEMS BASED ON POLY(DL-LACTIC-CO-GLYCOLIC ACID) (PLGA) FOR PHOTODYNAMIC THERAPY (PDT)'
[patent_app_type] => utility
[patent_app_number] => 12/941447
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5535
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275686.pdf
[firstpage_image] =>[orig_patent_app_number] => 12941447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941447 | NANOPARTICLE CARRIER SYSTEMS BASED ON POLY(DL-LACTIC-CO-GLYCOLIC ACID) (PLGA) FOR PHOTODYNAMIC THERAPY (PDT) | Nov 7, 2010 | Abandoned |
Array
(
[id] => 5944932
[patent_doc_number] => 20110105552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 12/941371
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12282
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105552.pdf
[firstpage_image] =>[orig_patent_app_number] => 12941371
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941371 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | Nov 7, 2010 | Abandoned |
Array
(
[id] => 8465763
[patent_doc_number] => 20120270931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'STABLE PHARMACEUTICAL FORMULATIONS COMPRISING LUBIPROSTONE'
[patent_app_type] => utility
[patent_app_number] => 13/505877
[patent_app_country] => US
[patent_app_date] => 2010-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6160
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505877
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505877 | Stable pharmaceutical formulations comprising lubiprostone | Nov 2, 2010 | Issued |
Array
(
[id] => 8465767
[patent_doc_number] => 20120270935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/505496
[patent_app_country] => US
[patent_app_date] => 2010-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13680
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505496
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505496 | FORMULATIONS | Oct 31, 2010 | Abandoned |
Array
(
[id] => 6070234
[patent_doc_number] => 20110045084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'LIGHT-CURABLE BONE GROWTH MATERIAL FOR TREATING DENTAL BONE DEFECTS'
[patent_app_type] => utility
[patent_app_number] => 12/913241
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7539
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045084.pdf
[firstpage_image] =>[orig_patent_app_number] => 12913241
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/913241 | LIGHT-CURABLE BONE GROWTH MATERIAL FOR TREATING DENTAL BONE DEFECTS | Oct 26, 2010 | Abandoned |
Array
(
[id] => 10534804
[patent_doc_number] => 09260424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-16
[patent_title] => '4,6-diaminopyrimidine stimulators of soluble guanylate cyclase'
[patent_app_type] => utility
[patent_app_number] => 12/911268
[patent_app_country] => US
[patent_app_date] => 2010-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10196
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12911268
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/911268 | 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase | Oct 24, 2010 | Issued |
Array
(
[id] => 7511426
[patent_doc_number] => 20110257136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Ophthalmic Formulations Of Cetirizine And Methods Of Use'
[patent_app_type] => utility
[patent_app_number] => 12/888117
[patent_app_country] => US
[patent_app_date] => 2010-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 35005
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257136.pdf
[firstpage_image] =>[orig_patent_app_number] => 12888117
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/888117 | Ophthalmic formulations of cetirizine and methods of use | Sep 21, 2010 | Issued |
Array
(
[id] => 6202892
[patent_doc_number] => 20110065678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'ISOXAZOLIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/878113
[patent_app_country] => US
[patent_app_date] => 2010-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43503
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065678.pdf
[firstpage_image] =>[orig_patent_app_number] => 12878113
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/878113 | Isoxazolidine derivatives | Sep 8, 2010 | Issued |
Array
(
[id] => 8858168
[patent_doc_number] => 08460701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide'
[patent_app_type] => utility
[patent_app_number] => 12/874443
[patent_app_country] => US
[patent_app_date] => 2010-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 14674
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12874443
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/874443 | Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide | Sep 1, 2010 | Issued |
Array
(
[id] => 10141049
[patent_doc_number] => 09173836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Pharmaceutical preparations for treatments of diseases and disorders of the breast'
[patent_app_type] => utility
[patent_app_number] => 12/871678
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9665
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12871678
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/871678 | Pharmaceutical preparations for treatments of diseases and disorders of the breast | Aug 29, 2010 | Issued |
Array
(
[id] => 6055714
[patent_doc_number] => 20110112074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'CHLOROTHIOPHENE-ISOXAZOLES AS INHIBITORS OF COAGULATION FACTORS XA AND THROMBIN'
[patent_app_type] => utility
[patent_app_number] => 12/858981
[patent_app_country] => US
[patent_app_date] => 2010-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19427
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112074.pdf
[firstpage_image] =>[orig_patent_app_number] => 12858981
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/858981 | Chlorothiophene-isoxazoles as inhibitors of coagulation factors Xa and thrombin | Aug 17, 2010 | Issued |
Array
(
[id] => 6026222
[patent_doc_number] => 20110053947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/852216
[patent_app_country] => US
[patent_app_date] => 2010-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50291
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053947.pdf
[firstpage_image] =>[orig_patent_app_number] => 12852216
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/852216 | Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof | Aug 5, 2010 | Abandoned |
Array
(
[id] => 6071254
[patent_doc_number] => 20110046105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/852233
[patent_app_country] => US
[patent_app_date] => 2010-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47364
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046105.pdf
[firstpage_image] =>[orig_patent_app_number] => 12852233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/852233 | Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof | Aug 5, 2010 | Abandoned |
Array
(
[id] => 6071334
[patent_doc_number] => 20110046185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/852188
[patent_app_country] => US
[patent_app_date] => 2010-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41344
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046185.pdf
[firstpage_image] =>[orig_patent_app_number] => 12852188
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/852188 | Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof | Aug 5, 2010 | Abandoned |
Array
(
[id] => 11304754
[patent_doc_number] => 09512139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Conformationally constrained, fully synthetic macrocyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 13/508531
[patent_app_country] => US
[patent_app_date] => 2010-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 142213
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508531
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508531 | Conformationally constrained, fully synthetic macrocyclic compounds | Aug 2, 2010 | Issued |
Array
(
[id] => 9648838
[patent_doc_number] => 08802850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Cyclopropyl modulators of P2Y12 receptor'
[patent_app_type] => utility
[patent_app_number] => 12/844017
[patent_app_country] => US
[patent_app_date] => 2010-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20949
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12844017
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/844017 | Cyclopropyl modulators of P2Y12 receptor | Jul 26, 2010 | Issued |